{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T17:02:12Z","timestamp":1794934932604,"version":"4.9.1"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T00:00:00Z","timestamp":1721088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000769","name":"University of Oxford","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Oxford Biomedical Research Centre"},{"DOI":"10.13039\/501100012091","name":"NIHR Clinical Research Network Thames Valley and South Midlands","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012091","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Pneumococcal carriage in healthy adults and its relationship to invasive pneumococcal disease (IPD) is not well understood.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Nasal wash samples from adults without close contact with young children (Liverpool, UK), 2011\u20132019, were cultured, and culture-negative samples tested by polymerase chain reaction (PCR). Pneumococcal carriage in adults 18\u201344 years was compared with carriage among pneumococcal conjugate vaccine\u2013vaccinated children aged 13\u201348 months (nasopharyngeal swabs, Thames Valley, UK) and national IPD data, 2014\u20132019. Age group\u2013specific serotype invasiveness was calculated and used with national IPD data to estimate carriage serotype distributions for \u226565 years.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Overall, 98 isolates (97 carriers) were identified (3 solely by PCR) from 1631 \u226518 years adults (standardized carriage prevalence 6.4%). Despite different carriage and IPD serotype distributions between adults and children, serotype invasiveness was highly correlated (R = 0.9). Serotypes 3, 37, and 8 represented a higher proportion of adult carriage than expected. Predicted carriage serotype distributions for \u226565 years aligned closest with the young adult carriage serotype distribution.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Nasal wash technique is highly sensitive. For some serotypes carried by adults aged \u226565 years, other adults may be an important reservoir for transmission. Age groups such as older children should also be considered.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/infdis\/jiae351","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T12:55:24Z","timestamp":1721048124000},"page":"e17-e27","source":"Crossref","is-referenced-by-count":12,"title":["Pneumococcal Carriage and Disease in Adults in England, 2011\u20132019: The Importance of Adults as a Reservoir for Pneumococcus in Communities"],"prefix":"10.1093","volume":"231","author":[{"given":"Dima","family":"El Safadi","sequence":"first","affiliation":[{"name":"Department of Clinical Sciences, Liverpool School of Tropical Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Hitchins","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Liverpool School of Tropical Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7627-6228","authenticated-orcid":false,"given":"Ashleigh","family":"Howard","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Liverpool School of Tropical Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvinder","family":"Aley","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford"},{"name":"National Institute for Health and Care Research, Oxford Biomedical Research Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaclyn","family":"Bowman","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Bertran","sequence":"additional","affiliation":[{"name":"Immunisations and Vaccine Preventable Diseases, UK Health Security Agency , London"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Collins","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Liverpool School of Tropical Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Colin-Jones","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filora","family":"Elterish","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman K","family":"Fry","sequence":"additional","affiliation":[{"name":"Immunisations and Vaccine Preventable Diseases, UK Health Security Agency , London"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen S","family":"Gordon","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Liverpool School of Tropical Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Gould","sequence":"additional","affiliation":[{"name":"Institute for Infection and Immunity, St George's University , London"},{"name":"BUGS Bioscience, London Bioscience Innovation Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Hinds","sequence":"additional","affiliation":[{"name":"Institute for Infection and Immunity, St George's University , London"},{"name":"BUGS Bioscience, London Bioscience Innovation Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Horn","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Liverpool School of Tropical Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Hyder-Wright","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Liverpool School of Tropical Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rama","family":"Kandasamy","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamez","family":"Ladhani","sequence":"additional","affiliation":[{"name":"Immunisations and Vaccine Preventable Diseases, UK Health Security Agency , London"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Litt","sequence":"additional","affiliation":[{"name":"Immunisations and Vaccine Preventable Diseases, UK Health Security Agency , London"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Mitsi","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Liverpool School of Tropical Medicine"},{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabel","family":"Murphy","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Liverpool School of Tropical Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J","family":"Pollard","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Plested","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford"},{"name":"National Institute for Health and Care Research, Oxford Biomedical Research Centre"},{"name":"National Institute for Health Research Clinical Research Network, Thames Valley and South Midlands , Oxford"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherin","family":"Pojar","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Liverpool School of Tropical Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Ratcliffe","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C","family":"Robertson","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Liverpool School of Tropical Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Robinson","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford"},{"name":"National Institute for Health and Care Research, Oxford Biomedical Research Centre"},{"name":"National Institute for Health Research Clinical Research Network, Thames Valley and South Midlands , Oxford"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D","family":"Snape","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford"},{"name":"National Institute for Health and Care Research, Oxford Biomedical Research Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Sol\u00f3rzano","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Liverpool School of Tropical Medicine"},{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6324-6559","authenticated-orcid":false,"given":"Merryn","family":"Voysey","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1287-5416","authenticated-orcid":false,"given":"Elizabeth","family":"Begier","sequence":"additional","affiliation":[{"name":"Pfizer Vaccines, Pfizer Inc , Collegeville, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Catusse","sequence":"additional","affiliation":[{"name":"Pfizer Vaccines, Pfizer Inc , Collegeville, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Lahuerta","sequence":"additional","affiliation":[{"name":"Pfizer Vaccines, Pfizer Inc , Collegeville, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0821-9202","authenticated-orcid":false,"given":"Christian","family":"Theilacker","sequence":"additional","affiliation":[{"name":"Pfizer Vaccines, Pfizer Inc , Collegeville, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6216-7194","authenticated-orcid":false,"given":"Bradford D","family":"Gessner","sequence":"additional","affiliation":[{"name":"Pfizer Vaccines, Pfizer Inc , Collegeville, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2125-4125","authenticated-orcid":false,"given":"Karen S","family":"Tiley","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4017-5425","authenticated-orcid":false,"given":"Daniela M","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Liverpool School of Tropical Medicine"},{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,7,16]]},"reference":[{"key":"2025020417122319400_jiae351-B1","doi-asserted-by":"crossref","first-page":"e00937-20","DOI":"10.1128\/mBio.00937-20","article-title":"A new pneumococcal capsule type, 10D, is the 100th serotype and has a large cps fragment from an oral Streptococcus","volume":"11","author":"Ganaie","year":"2020","journal-title":"mBio"},{"key":"2025020417122319400_jiae351-B2","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1473-3099(11)70090-1","article-title":"Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study","volume":"11","author":"Miller","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"2025020417122319400_jiae351-B3","volume-title":"Pneumococcal: the Green book, chapter 25.","author":"UK Health Security Agency, Department of Health & Social Care","year":"2023"},{"key":"2025020417122319400_jiae351-B4","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1473-3099(18)30052-5","article-title":"Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000\u201317: a prospective national observational cohort study","volume":"18","author":"Ladhani","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2025020417122319400_jiae351-B5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s41479-017-0039-9","article-title":"Community-acquired pneumonia in the United Kingdom: a call to action","volume":"9","author":"Chalmers","year":"2017","journal-title":"Pneumonia (Nathan)"},{"key":"2025020417122319400_jiae351-B6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12890-016-0242-0","article-title":"A systematic review of the burden of vaccine preventable pneumococcal disease in UK adults","volume":"16","author":"Chalmers","year":"2016","journal-title":"BMC Pulm Med"},{"key":"2025020417122319400_jiae351-B7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/thx.2009.129502","article-title":"Clinical and economic burden of community-acquired pneumonia among adults in Europe","volume":"67","author":"Welte","year":"2012","journal-title":"Thorax"},{"key":"2025020417122319400_jiae351-B8"},{"key":"2025020417122319400_jiae351-B9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.15585\/mmwr.mm7104a1","article-title":"Use of 15-valent pneumococcal conjugate vaccine and 20-valent pneumococcal conjugate vaccine among U.S. adults: updated recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2022","volume":"71","author":"Kobayashi","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025020417122319400_jiae351-B10","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1016\/j.vaccine.2015.04.025","article-title":"Safety, tolerability, and immunogenicity of 15-valent pneumococcal conjugate vaccine in healthy adults","volume":"33","author":"McFetridge","year":"2015","journal-title":"Vaccine"},{"key":"2025020417122319400_jiae351-B11","doi-asserted-by":"crossref","first-page":"6201","DOI":"10.1016\/j.vaccine.2019.08.048","article-title":"Phase 1 trial of a 20-valent pneumococcal conjugate vaccine in healthy adults","volume":"37","author":"Thompson","year":"2019","journal-title":"Vaccine"},{"key":"2025020417122319400_jiae351-B12"},{"key":"2025020417122319400_jiae351-B13","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1586\/erv.12.53","article-title":"The fundamental link between pneumococcal carriage and disease","volume":"11","author":"Simell","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"2025020417122319400_jiae351-B14","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1164\/rccm.201212-2277OC","article-title":"Controlled human infection and rechallenge with Streptococcus pneumoniae reveals the protective efficacy of carriage in healthy adults","volume":"187","author":"Ferreira","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2025020417122319400_jiae351-B15","doi-asserted-by":"crossref","first-page":"O1145","DOI":"10.1111\/1469-0691.12752","article-title":"Density and duration of experimental human pneumococcal carriage","volume":"20","author":"Gritzfeld","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"2025020417122319400_jiae351-B16","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/infdis\/jiac376","article-title":"Nasopharyngeal carriage of pneumococcus in children in England up to 10 years after 13-valent pneumococcal conjugate vaccine introduction: persistence of serotypes 3 and 19A and emergence of 7C","volume":"227","author":"Tiley","year":"2023","journal-title":"J Infect Dis"},{"key":"2025020417122319400_jiae351-B17","first-page":"1361","article-title":"Persistent circulation of vaccine serotypes and serotype replacement after 5 years of infant immunization with 13-valent pneumococcal conjugate vaccine in the United Kingdom","volume":"221","author":"Kandasamy","year":"2020","journal-title":"J Infect Dis"},{"key":"2025020417122319400_jiae351-B18"},{"key":"2025020417122319400_jiae351-B19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.vaccine.2013.08.062","article-title":"Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: updated recommendations from the World Health Organization pneumococcal carriage working group","volume":"32","author":"Satzke","year":"2013","journal-title":"Vaccine"},{"key":"2025020417122319400_jiae351-B20"},{"key":"2025020417122319400_jiae351-B21","doi-asserted-by":"crossref","first-page":"e0119875","DOI":"10.1371\/journal.pone.0119875","article-title":"Carriage of Streptococcus pneumoniae in aged adults with influenza-like-illness","volume":"10","author":"Krone","year":"2015","journal-title":"PLoS One"},{"key":"2025020417122319400_jiae351-B22","doi-asserted-by":"crossref","first-page":"e335","DOI":"10.1097\/MD.0000000000000335","article-title":"A cross-sectional observational study of pneumococcal carriage in children, their parents, and older adults following the introduction of the 7-valent pneumococcal conjugate vaccine","volume":"94","author":"Hamaluba","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"2025020417122319400_jiae351-B23","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1016\/j.vaccine.2014.03.017","article-title":"Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England","volume":"32","author":"van Hoek","year":"2014","journal-title":"Vaccine"},{"key":"2025020417122319400_jiae351-B24","doi-asserted-by":"crossref","first-page":"e0195799","DOI":"10.1371\/journal.pone.0195799","article-title":"Pneumococcal carriage in children and their household contacts six years after introduction of the 13-valent pneumococcal conjugate vaccine in England","volume":"13","author":"Southern","year":"2018","journal-title":"PLoS One"},{"key":"2025020417122319400_jiae351-B25","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/14760584.2020.1750378","article-title":"Upper respiratory tract colonization with Streptococcus pneumoniae in adults","volume":"19","author":"Arguedas","year":"2020","journal-title":"Expert Rev Vaccines"},{"key":"2025020417122319400_jiae351-B26","doi-asserted-by":"crossref","first-page":"e768","DOI":"10.1093\/cid\/ciaa1480","article-title":"Serotype patterns of pneumococcal disease in adults are correlated with carriage patterns in older children","volume":"72","author":"Wyllie","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2025020417122319400_jiae351-B27","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/aje\/kwv283","article-title":"Relating pneumococcal carriage among children to disease rates among adults before and after the introduction of conjugate vaccines","volume":"183","author":"Weinberger","year":"2016","journal-title":"Am J Epidemiol"},{"key":"2025020417122319400_jiae351-B28","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1086\/423820","article-title":"Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children","volume":"190","author":"Brueggemann","year":"2004","journal-title":"J Infect Dis"},{"key":"2025020417122319400_jiae351-B29","doi-asserted-by":"crossref","first-page":"e1009389","DOI":"10.1371\/journal.pcbi.1009389","article-title":"Analysing pneumococcal invasiveness using Bayesian models of pathogen progression rates","volume":"18","author":"L\u00f8chen","year":"2022","journal-title":"PLoS Comput Biol"},{"key":"2025020417122319400_jiae351-B30","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1016\/j.vaccine.2024.03.041","article-title":"Streptococcus pneumoniae as a colonizing agent of the nasopharynx\u2014oropharynx in adults: a systematic review and meta-analysis","volume":"42","author":"Lozada","year":"2024","journal-title":"Vaccine"},{"key":"2025020417122319400_jiae351-B31","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1371\/journal.pmed.0050074","article-title":"Social contacts and mixing patterns relevant to the spread of infectious diseases","volume":"5","author":"Mossong","year":"2008","journal-title":"PLoS Med"},{"key":"2025020417122319400_jiae351-B32","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.socnet.2007.04.005","article-title":"Mixing patterns between age groups in social networks","volume":"29","author":"Del Valle","year":"2007","journal-title":"Soc Netw"},{"key":"2025020417122319400_jiae351-B33"},{"key":"2025020417122319400_jiae351-B34","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S1473-3099(10)70251-6","article-title":"Meningococcal carriage by age: a systematic review and meta-analysis","volume":"10","author":"Christensen","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"2025020417122319400_jiae351-B35","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/21645515.2018.1528831","article-title":"Meningococcal disease in adolescents and young adults: a review of the rationale for prevention through vaccination","volume":"15","author":"Burman","year":"2019","journal-title":"Hum Vaccines Immunother"},{"key":"2025020417122319400_jiae351-B36","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1136\/bmj.320.7238.846","article-title":"Changing carriage rate of Neisseria meningitidis among university students during the first week of term: cross sectional study","volume":"320","author":"Neal","year":"2000","journal-title":"BMJ"},{"key":"2025020417122319400_jiae351-B37","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1093\/infdis\/jiaa558","article-title":"Dynamics of pneumococcal carriage in adults: a new look at an old paradigm","volume":"223","author":"Almeida","year":"2021","journal-title":"J Infect Dis"},{"key":"2025020417122319400_jiae351-B38"},{"key":"2025020417122319400_jiae351-B39","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S1473-3099(23)00706-5","article-title":"Invasive pneumococcal disease 3 years after introduction of a reduced 1 + 1 infant 13-valent pneumococcal conjugate vaccine immunisation schedule in England: a prospective national observational surveillance study","volume":"24","author":"Bertran","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2025020417122319400_jiae351-B40","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1164\/rccm.201811-2081LE","article-title":"Two randomized trials of the effect of live attenuated influenza vaccine on pneumococcal colonization","volume":"199","author":"Rylance","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2025020417122319400_jiae351-B41","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.3201\/eid2511.190157","article-title":"Nasopharyngeal pneumococcal density during asymptomatic respiratory virus infection and risk for subsequent acute respiratory illness","volume":"25","author":"Howard","year":"2019","journal-title":"Emerg Infect Dis"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiae351\/58682049\/jiae351.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/231\/1\/e17\/58682049\/jiae351.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/231\/1\/e17\/58682049\/jiae351.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T17:17:11Z","timestamp":1738689431000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/231\/1\/e17\/7714969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,16]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,7,16]]},"published-print":{"date-parts":[[2025,2,4]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiae351","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,1,15]]},"published":{"date-parts":[[2024,7,16]]}}}